A decade after US approval, Novartis’ Gilenya scores marketing authorisation in China for relapsing multiple sclerosis
July 19, 2019Medical Communications, Sales and Marketing Novartis, gilenya, multiple sclerosis, pharma
Novartis has revealed that its disease modifying drug Gilenya (fingolimod) has secured approval in China for the treatment of relapsing …
DRC rules out trialling experimental Ebola vaccines
July 19, 2019Medical Communications Congo, DRC, Ebola, Ebola vaccine, pharma
The Democratic Republic of Congo (DRC) has said it will stick with Merck’s rVSV-ZEBOV ebola vaccine, as it ruled out …
Royal Pharmaceutical Society in Scotland says contingency plans do not mitigate risk of no-deal Brexit
July 19, 2019Medical Communications RPS, brexit, no-deal Brexit, pharma, pharmaceuticals
The Royal Pharmaceutical Society (RPS) in Scotland has raised concerns that the Government’s contingency plans do not eliminate the risks …
Dr John McHutchinson steps down from Gilead with $1.1 million goodbye
July 18, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Gilead has said that Dr John McHutchison is stepping down after nine years at the firm. Gilead’s Chief Scientific Officer …
“Little to no progress” made in achieving gender representation within top pharma firms, report says
July 18, 2019Manufacturing and Production, Medical Communications female representation, gender equality, pharma
The release of Women Count 2019, an annual report funded by The Pipeline, has revealed that “little to no progress” …
FDA approves MSD’s combo therapy Recarbrio for urinary tract and intra-abdominal infections
July 18, 2019Sales and Marketing FDA, MSD, Recarbrio, US, pharma, urinary tract
MSD has announced the approval from the FDA of its combination therapy Recarbrio (imipenem, cilastatin and relebactam) in the treatment …
Novartis CEO sets aside $700 million to settle bribery lawsuit
July 18, 2019Business Services, Sales and Marketing Novartis, bribery, lawsuit, pharma, sales
Vas Narasimhan, Novartis’ CEO, has set aside $700 million to settle a bribery lawsuit in the United States. Speaking in …
WHO declares global public health emergency over Ebola outbreak in Congo
July 18, 2019Medical Communications DRC, Democratic Republic of Congo, Ebola, WHO, pharma
The World Health Organization (WHO) has said the Ebola outbreak in the Democratic Republic of Congo (DRC) is a global …
Louvre takes down all references to Purdue-owning Sackler family
July 17, 2019Medical Communications Art, Louvre, PR, Purdue Pharma, Sacklers, donations
The Louvre taken down references to the Sacklers, the billionaire owners of Purdue Pharma. The largest art gallery in the …
Autonomous drone successfully delivers temperature-controlled drugs in test programme
July 17, 2019Research and Development, Sales and Marketing Drones, humanitarian aid, pharma
A humanitarian consortium has successfully completed a testing programme for the delivery of temperature-controlled medicines via the use of unmanned …
NICE greenlights Novartis Kisqali combo in HR+/HER2- advanced breast cancer
July 17, 2019Manufacturing and Production, Medical Communications, Research and Development Cancer, Kisqali, NICE, Novartis, UK, breast cancer, pharma
Novartis’ Kisqali (ribociclib) has secured recommendation from NICE in combination with fulvestrant, meaning the cyclin-dependent kinase 4 and 6 (CDK4/6) …
Roche signs deal with Skyhawk over molecules that modulate RNA splicing
July 17, 2019Research and Development Genentech, Roche, Skyhawk, drug development, rna splicing
Roche’s Genentech unit has signed a deal with Massachusetts-based firm Skyhawk Therapeutics to develop and commercialise small molecules that modulate …
Genentech signs $1 billion deal with Sosei over GCPRs
July 17, 2019Research and Development Genentech, Roche, gcprs, pharma, sosei
Roche’s Genentech has entered into a partnership with Sosei Heptares to develop small molecules and biologics that G protein-coupled receptor …
AstraZeneca to switch entire fleet to electric vehicles by 2030
July 17, 2019Research and Development AstraZeneca, EV100, electric vehicles, environmentalism, pharma, renewables
AstraZeneca has revealed plans to use only electric vehicles by 2030. In joining the EV100 group, AstraZeneca will transfer the …
Bayer’s Gadavist becomes first FDA-approved drug for MRI in coronary artery disease patients
July 16, 2019Manufacturing and Production, Sales and Marketing Bayer, FDA, Gadavist, coronary artery disease, pharma
The FDA has awarded approval to Bayer’s Gadavist (gadobutrol) injection, the company confirmed.
Capricor’s share price rockets up by 150% on Phase 2 Duchenne muscular dystrophy success
July 16, 2019Manufacturing and Production, Research and Development CAP-1002, Capricor Therapeutics, Duchenne Muscular Dystrophy, pharma
Capricor Therapeutics has unveiled impactful new Phase 2 data for its investigational allogeneic cardiosphere-derived cell therapy CAP-1002 in the treatment …
Oklahoma lawyers say J&J is kingpin of pharmaceutical cartel
July 16, 2019Manufacturing and Production J&J, JJ, Oklahoma, opioid crisis, opioids, pharma
Lawyers representing the State of Oklahoma described Johnson & Johnson as the ‘kingpin’ in a ‘pharmaceutical cartel’ as they accused …
GSK teams up with Strathclyde and University of Nottingham
July 16, 2019Manufacturing and Production GSK, GlaxoSmithKline, UK, britain, pharma, universities
GlaxoSmithKline has teamed up with the University of Nottingham and the University of Strathclyde for a five-year partnership aimed at …
Boehringer buys cancer vaccine company AMAL Therapeutics for €325 million
July 16, 2019Manufacturing and Production AMAL Therapeutics, Boehringer Ingelheim, Geneva, cancer vaccines, oncology
Boehringer Ingelheim has bought Swiss biotech AMAL Therapeutics, a company focused on cancer immunotherapy and cancer vaccines. AMAL’s lead candidate, …
Darius Hughes, Head of Vaccines Business Unit UK, Pfizer
July 15, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Darius Hughes, Pfizer, Working Life, biotech, pharma, vaccines
“Vaccines provide a unique opportunity to have a positive effect on hundreds of thousands of people” – Darius Hughes, Head …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
